Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
XXXVII Congreso SETH 2021.indd
XXXVII Congreso SETH 2021.indd
Guideline Therapeutics and COVID-19: living guideline
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
XXXVII Congreso SETH 2021.indd
Antioxidants | Free Full-Text | The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
XXXVII Congreso SETH 2021.indd
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
Comunicaciones orales
Guideline Therapeutics and COVID-19: living guideline
XXXVII Congreso SETH 2021.indd
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody Assay | SpringerLink
NORTH SAILS 603154 - Parka
Frontiers | The Mechanism of Lung and Intestinal Injury in Acute Pancreatitis: A Review
Traditionell cowboy västerländsk läderjacka brun kappa med frans indiansk jacka mocka, Svart, XL : Amazon.se: Mode
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants | Signal Transduction and Targeted Therapy
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
